Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | September 04, 2024 |
| PDB ID | UniProt ID | Title ▲ | Descriptor |
|---|---|---|---|
| 8ONI | P01308 | Human insulin in complex with the analytical antibody S1 Fab | |
| 8ONI | 8ONI | Human insulin in complex with the analytical antibody S1 Fab | |
| 6VEP | P01308 | Human insulin in complex with the human insulin microreceptor in turn in complex with Fv 83-7 | |
| 6VEP | 6VEP | Human insulin in complex with the human insulin microreceptor in turn in complex with Fv 83-7 | |
| 6VEP | P06213 | Human insulin in complex with the human insulin microreceptor in turn in complex with Fv 83-7 | |
| 5J3H | 5J3H | Human insulin receptor domains L1-CR in complex with peptide S519C16 and 83-7 Fv | |
| 5J3H | P06213 | Human insulin receptor domains L1-CR in complex with peptide S519C16 and 83-7 Fv | |
| 5IUE | B3KUD8 | Human leukocyte antigen F (HLA-F) presents peptides and regulates immunity through interactions with NK-cell receptors | |
| 5IUE | P61769 | Human leukocyte antigen F (HLA-F) presents peptides and regulates immunity through interactions with NK-cell receptors | |
| 5IUE | 5IUE | Human leukocyte antigen F (HLA-F) presents peptides and regulates immunity through interactions with NK-cell receptors | |
| 5KNM | B3KUD8 | Human leukocyte antigen F (HLA-F) presents peptides and regulates immunity through interactions with NK-cell receptors | |
| 5KNM | P61769 | Human leukocyte antigen F (HLA-F) presents peptides and regulates immunity through interactions with NK-cell receptors | |
| 5KNM | Q8NHL6 | Human leukocyte antigen F (HLA-F) presents peptides and regulates immunity through interactions with NK-cell receptors | |
| 5KNM | 5KNM | Human leukocyte antigen F (HLA-F) presents peptides and regulates immunity through interactions with NK-cell receptors | |
| 3B29 | Q16873 | Human leukotriene C4 synthase in complex with dodecyl-beta-D-selenomaltoside | |
| 5Q0C | O00757 | Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, E.C.3.1.3.11) complexed with the allosteric inhibitor 1-(5-bromo-1,3-thiazol-2-yl)-3-[5-(4-methoxyphenyl)thiophen-2-yl]sulfonylurea and with fructose-2,6-diphosphate | |
| 3CEH | P06737 | Human liver glycogen phosphorylase (tense state) in complex with the allosteric inhibitor AVE5688 | Glycogen phosphorylase (E.C.2.4.1.1) |
| 1L5Q | P06737 | Human liver glycogen phosphorylase a complexed with caffeine, N-Acetyl-beta-D-glucopyranosylamine, and CP-403700 | Glycogen phosphorylase, liver form (E.C.2.4.4.1) |
| 2ZB2 | P06737 | Human liver glycogen phosphorylase a complexed with glcose and 5-chloro-N-[4-(1,2-dihydroxyethyl)phenyl]-1H-indole-2-carboxamide | |
| 1L5R | P06737 | Human liver glycogen phosphorylase a complexed with riboflavin, N-Acetyl-beta-D-Glucopyranosylamine and CP-403,700 | glycogen phosphorylase, liver form (E.C.2.4.4.1) |
| 1L7X | P06737 | Human liver glycogen phosphorylase b complexed with caffeine, N-acetyl-beta-D-glucopyranosylamine, and CP-403,700 | Glycogen phosphorylase, liver form (E.C.2.4.1.1.) |
| 1L5S | P06737 | Human liver glycogen phosphorylase complexed with uric acid, N-Acetyl-beta-D-glucopyranosylamine, and CP-403,700 | Glycogen phosphorylase, liver form (E.C.2.4.4.1) |
| 1NOW | p07686 | Human lysosomal beta-hexosaminidase isoform B in complex with (2R,3R,4S,5R)-2-Acetamido-3,4-Dihydroxy-5-Hydroxymethyl-Piperidinium Chloride (GalNAc-isofagomine) | Beta-hexosaminidase beta chain (E.C.3.2.1.52) |
| 1NP0 | P07686 | Human lysosomal beta-hexosaminidase isoform B in complex with intermediate analogue NAG-thiazoline | |
| 6BT5 | O00222 | Human mGlu8 Receptor complexed with L-AP4 | |
| 6BSZ | O00222 | Human mGlu8 Receptor complexed with glutamate | |
| 7UAE | Q16819 | Human meprin alpha (active state) | |
| 7UAF | Q16819 | Human meprin alpha inhibitory complex with compound 10d (N~3~,N~3~-bis[(2H-1,3-benzodioxol-5-yl)methyl]-N-hydroxy-beta-alaninamide) | |
| 4U32 | P35030 | Human mesotrypsin complexed with HAI-2 Kunitz domain 1 | |
| 4U32 | O43291 | Human mesotrypsin complexed with HAI-2 Kunitz domain 1 | |
| 6UO8 | Q9UBS5 | Human metabotropic GABA(B) receptor bound to agonist SKF97541 and positive allosteric modulator GS39783 | Gamma-aminobutyric acid type B receptor subunit 1, Gamma-aminobutyric acid type B receptor subunit 2 |
| 6UO8 | O75899 | Human metabotropic GABA(B) receptor bound to agonist SKF97541 and positive allosteric modulator GS39783 | Gamma-aminobutyric acid type B receptor subunit 1, Gamma-aminobutyric acid type B receptor subunit 2 |
| 6UO9 | Q9UBS5 | Human metabotropic GABA(B) receptor bound to agonist SKF97541 in its intermediate state 2 | Gamma-aminobutyric acid type B receptor subunit 1, Gamma-aminobutyric acid type B receptor subunit 2 |
| 6UO9 | O75899 | Human metabotropic GABA(B) receptor bound to agonist SKF97541 in its intermediate state 2 | Gamma-aminobutyric acid type B receptor subunit 1, Gamma-aminobutyric acid type B receptor subunit 2 |
| 6VJM | Q9UBS5 | Human metabotropic GABA(B) receptor in its apo state | Gamma-aminobutyric acid type B receptor subunit 1, Gamma-aminobutyric acid type B receptor subunit 2 |
| 6VJM | O75899 | Human metabotropic GABA(B) receptor in its apo state | Gamma-aminobutyric acid type B receptor subunit 1, Gamma-aminobutyric acid type B receptor subunit 2 |
| 6UOA | Q9UBS5 | Human metabotropic GABA(B) receptor in its intermediate state 1 | Gamma-aminobutyric acid type B receptor subunit 1, Gamma-aminobutyric acid type B receptor subunit 2 |
| 6UOA | O75899 | Human metabotropic GABA(B) receptor in its intermediate state 1 | Gamma-aminobutyric acid type B receptor subunit 1, Gamma-aminobutyric acid type B receptor subunit 2 |
| 5C5C | Q14831 | Human metabotropic glutamate receptor 7, extracellular ligand binding domain | |
| 5NST | 5NST | Human monoclonal antibody with a LAIR1 insertion | |
| 5L0A | O00757 | Human muscle fructose-1,6-bisphosphatase E69Q mutant in active R-state in complex with fructose-1,6-bisphosphate | |
| 5K55 | O00757 | Human muscle fructose-1,6-bisphosphatase E69Q mutant in active R-state in complex with fructose-6-phosphate | |
| 3IFC | O00757 | Human muscle fructose-1,6-bisphosphatase E69Q mutant in complex with AMP and alpha fructose-6-phosphate | |
| 5K56 | O00757 | Human muscle fructose-1,6-bisphosphatase in active R-state in complex with fructose-1,6-bisphosphate | |
| 5ET8 | O00757 | Human muscle fructose-1,6-bisphosphatase in active R-state in complex with fructose-6-phosphate | |
| 8IYG | Q9UKL4 | Human neuronal gap junction channel connexin 36 | |
| 3QUD | Q16539 | Human p38 MAP Kinase in Complex with 2-amino-phenylamino-benzophenone | |
| 3L8S | Q16539 | Human p38 MAP Kinase in Complex with CP-547632 | |
| 3LFA | Q16539 | Human p38 MAP Kinase in Complex with Dasatinib | |
| 5TCO | Q16539 | Human p38 MAP Kinase in Complex with Dibenzosuberone Compound 1 |
